The utility of aminoglycosides in an era of emerging drug resistance
- 1 May 1998
- journal article
- review article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 10 (2) , 95-105
- https://doi.org/10.1016/s0924-8579(98)00033-8
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Editorial Response: Single Daily Dosing of Aminoglycosides--A Concept Whose Time Has Not Yet ComeClinical Infectious Diseases, 1997
- Editorial Response: Meta-Analyses Are No Longer Required for Determining the Efficacy of Single Daily Dosing of AminoglycosidesClinical Infectious Diseases, 1997
- In-vitro killing activity of combinations of beta-lactam agents with aminoglycosides against penicillin-resistant pneumococciJournal of Antimicrobial Chemotherapy, 1997
- Activity of the semi-synthetic kanamycin B derivative, arbekacin against methicillin-resistant Staphylococcus aureusJournal of Antimicrobial Chemotherapy, 1995
- The lethal action of aminoglycosideJournal of Antimicrobial Chemotherapy, 1988
- Effect of Highly Potent Antipseudomonal β-Lactam Agents Alone and in Combination with Aminoglycosides Against Pseudomonas aeruginosaClinical Infectious Diseases, 1984
- Aminoglycoside nephrotoxicity: a double blind prospective randomized study of gentamicin and tobramycinJournal of Antimicrobial Chemotherapy, 1982
- Aminoglycoside Nephrotoxicity and its PredictabilityNephron, 1981
- Saturday ConferenceSouthern Medical Journal, 1978
- AminoglycosidesDrugs, 1976